PT  - JOURNAL ARTICLE
AU  - Malki, Monzr Al
AU  - Keyzner, Alla
AU  - Suh, Hyung C
AU  - Matin, Aasiya
AU  - Buonomo, Erica
AU  - Wang, Yun
AU  - Abelowitz, Nina
AU  - Murray, Jim
AU  - MacBeath, Gavin
AU  - Barton, Debora
AU  - Chattopadhyay, Shrikanta
AU  - Reshef, Ran
TI  - 682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation
AID  - 10.1136/jitc-2023-SITC2023.0682
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A774--A774
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A774.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A774.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.